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To the Editor: Obstructive sleep apnea (OSA), characterized by
partial or complete occlusion of the pharynx during sleep, results in
persistent inspiratory effort and interruption of airflow. During
each episode of apnea, OSA patients develop increased transmural
pressure in the aortic wall. Accordingly, to test the hypothesis that
the presence of OSA would be associated with greater thoracic
aortic size, we prospectively assessed 150 consecutive patients,
newly referred to the sleep clinic in our institution, in a cross-
sectional study to confirm OSA. The patients underwent sleep
study and chest computed tomography (CT)-derived thoracic
aortic diameter. In this particular period, a chest CT was per-
formed within 3 months of the sleep study upon informed consent
to our protocol. Exclusion criteria included: 1) prior history of
aortic dissection, aortic valvular disease, and clinical characteristics
of Marfan’s syndrome; 2) central sleep apnea; 3) treatment for
sleep apnea; and 4) dialysis. The outer diameter of the ascending
aorta was measured by caliper within the CT image. Overnight
sleep study was performed using cardiopulmonary monitoring
(Morpheus, Teijin Inc., Tokyo, Japan). The apnea-hypopnea
index (AHI) was quantified as the frequency of apneas and
hypopneas per hour of bed time. OSA was defined as AHI10/h.
The data are presented as mean  SD or frequencies. To
determine the independent factors, the multiple linear regression
model with backward elimination technique was used, including
older age, male gender, blood pressure, hypertension, dyslipidemia,
diabetes mellitus, ischemic heart disease, smoking, and AHI.
Comparisons between the 2 groups were performed by Student t
test for the unadjusted aortic diameter and by analysis of covariance
for the adjusted aortic diameter.
The patients’ mean age was 60 11 years; 125 (83%) were men,
with mean body mass index of 24.7  3.1 kg/m2. Fifty-nine
percent of patients had hypertension. At assessment, 91% of
patients had already taken prescribed antihypertensive medica-
tions. One hundred ten patients (73%) had OSA. On univariate
analysis, older age, male gender, body mass index, systolic blood
pressure, pulse pressure, hypertension, dyslipidemia, ischemic
heart disease, and AHI were positively correlated with thoracic
aortic size. On multivariate analysis, older age (per 10-year
increase, coefficient 1.82, 95% confidence interval [CI]: 1.13 to
2.34, p  0.001), male gender (coefficient 3.25, 95% CI: 1.63 to
4.87, p  0.001), and AHI (per 10-event/h increase, coefficient
0.62, 95% CI: 0.25 to 0.98, p  0.001) remained as factors
associated with greater thoracic aortic diameter. Contrarily, there
was no significant independent relationship between blood
pressure/hypertension and thoracic aortic size. Additionally,
patients with OSA had a significantly greater thoracic aortic
size than those without OSA (p  0.001) (Fig. 1), even if
adjusted for older age and male gender (p  0.001).
Increased thoracic aortic size is known to be related to aging,
male, genetic mutation including Marfan’s syndrome, hyperten-
sion, and atherosclerosis. There are few published papers compa-
rable to this study. Cistulli et al. (1) reported 2 cases of Marfan’s
syndrome in which treatment of OSA by continuous positive
airway pressure associated with a marked attenuation in the aortic
dilatation. Sampol et al. (2) reported 19 patients with thoracic
aortic dissection who had a high prevalence of severe OSA. The
effect of hypertension on greater thoracic aortic size is accepted.
For example, Dapunt et al. (3) reported that a history of hyper-
tension was correlated with greater aortic size. However, Masuda
et al. (4) and we did not find a significant independent correlation
of blood pressure/hypertension on multivariate analysis; it may be
difficult to exclude such a correlation as an important contributor
to greater thoracic aortic size in already medicated patients. In
addition, OSA can contribute to the development of hypertension.
Our data suggested that OSA may contribute to increased thoracic
aortic size not only by causing hypertension but also through
mechanical stress on the aortic wall from repeated episodes of
apneas and hypopnea. Inspiratory effort against occluded upper
airway during an OSA episode results in negative intrathoracic
pressures as low as 80 cm H2O, which can affect intrathoracic
hemodynamics. Peters et al. (5) reported that, in rats, decreased
intrathoracic pressure during diastole can distend the intrathoracic
aorta. Thus, repeated episodes of sudden increments and changes
in the transmural pressure of the aortic wall could contribute to
Figure 1 Obstructive Sleep Apnea
and Ascending Aortic Diameter
Box plot showing ascending aortic diameter between patients without obstructive
sleep apnea (OSA) (n  40) and with OSA (n  110). Middle horizontal line inside
box indicates the means. The bottom and top of the box are the 25th and 75th
percentiles, respectively. Thoracic aortic size was significantly greater in patients
with OSA than in those without OSA (36.8  3.6 mm vs. 31.5  4.5 mm, p 
0.001), even if adjusted for older age and male gender (p  0.001).
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increased thoracic aortic size. Our observations had a main
limitation: because the present study was based on cross-sectional
data, it is difficult to prove that OSA accelerates aortic expansion.
The present study indicates that OSA could contribute to
greater thoracic aortic size.
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Letters to the Editor
Limitations of Angiographic
Predictors of Bypass Graft Patency
I compliment the work of Glineur et al. (1) on advancing our
appreciation of the physiologic predictors of 6-month patency rates
of bypass grafts to the right coronary artery. The patency of the
gastroepiploic artery (GEA) had a significant association with
minimal luminal diameter (MLD) and percent diameter stenosis,
angiographic features that did not affect saphenous vein graft
patency rates as much. A larger MLD (1.4 mm) and the percent
diameter stenosis (55% narrowing) predicted GEA graft closure.
The accompanying editorial by Sabik and Blackstone (2) expertly
reviewed the evidence for competitive flow and coronary artery
bypass graft patency, explaining some of the factors in play for the
outcomes reported by Glineur et al. (1).
Although competitive flow between native and grafted coronary
vessels has been known to surgeons for many years as a cause of
graft failure (3–5), the prediction of graft patency on the basis of
the physiology of competitive flow should not be judged by
angiography alone. The numerous studies on intracoronary pres-
sure and intravascular ultrasound imaging reinforce the failure of
the angiogram to provide important physiologic and true anatomic
information, especially for intermediately severe stenoses (6,7).
Using angiography as a surrogate for physiologic activity is often
erroneous and, at this time, is an imprecise technique when
addressing physiologic mechanisms as described by Sabik et al. (5)
and others (3,4). The competing flow potential of the native artery
with vein graft flow can be directly measured by coronary pressure
or Doppler flow in patients in the cardiac catheterization labora-
tory (6,8).
The measurement of hyperemic translesional pressure ratio,
called fractional flow reserve (FFR) (8,9), has been applied to study
the fate of coronary bypass grafts with striking results. Confirming
the relevance of the physiologic stenosis severity and graft patency,
Botman et al. (10) report the 1-year follow-up of 164 patients
undergoing coronary bypass grafts. All vessels grafted had FFR
measured beforehand with the pressure sensor angioplasty guide-
wire in the catheterization laboratory. At 1 year, 9% of grafts on
functionally significant lesions were occluded, whereas 21% of
grafts on functionally nonsignificant lesions were occluded. A
significant graft occlusion rate was observed for grafted vessels with
near normal physiology (FFR 0.80, normal  1.0). The angio-
graphic percent diameter narrowings displayed a similar but less
precise correlation with graft failure. The findings from Botman et
al. (10) again emphasize what is generally appreciated but unmea-
sured: that is, the physiologic impact of intermediately severe
stenosis remains unknown by angiography.
Whereas the angiographic descriptor of MLD provided by
Glineur et al. (1) is an advance over measurements of stenosis
diameter (even if using a quantitative angiographic imaging sys-
tem), the precise pressure across stenosis can be obtained often
without difficulty by most interventional cardiologists. Certainly,
severe narrowings and total occlusions do not need such direct
measurements, but the physiologic assessment of intermediate
lesions can assist selection of the appropriate bypass graft should
the surgeon have an interest in this approach (11).
Sabik and Blackstone (2) note that using only maximal coronary
artery stenosis would not adjust for coronary artery size, whereas
MLD does this to a larger extent. However, neither MLD of the
reference lumen diameter nor percent lumen diameter narrowing
truly reflects competitive flow physiology. Although I recognize
this might not be possible in many clinical settings, I believe
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